Document is current
Any future updates will be listed below
-
Authors
Lim, Jerald
Cho, Hannah
Ramkumar, Hema
Adrean, Sean D.
- License Information
-
More Information
Article History
Received: 30 August 2025
Accepted: 18 November 2025
First Online: 22 November 2025
Declarations
:
: This study adhered to the tenets of the Declaration of Helsinski. Local institutional review board (IRB) approval was obtained, IRB00012874; 2025-002-RCOC. All data was collected in accordance with the Health Insurance Portability and Accountability Act (HIPAA). Written informed consent was not required given the retrospective nature of this study.
: American Society of Retina Specialists annual meeting, Long Beach, CA 7/31/2025.
: Jerald Lim, B.S.: None. Hannah Cho, B.A.: None. Hema Ramkumar, M.D.: Grant support from Adverum, Alexion, Amgen, Apellis, Eyepoint Pharmaceuticals, Genentech, Iveric Bio, Kodiak Life Sciences, NGM Pharmaceuticals, Ocular Therepeutix Opthea, Regeneron Pharmaceuticals, Inc., REGENXBIO, and Rezolute; served as a consultant/advisor for Genentech and Ocular Therepeutix. Sean D. Adrean, M.D.: Grant support from Adverum, Alexion, Amgen, Apellis, Eyepoint Pharmaceuticals, Genentech, Iveric Bio, Kodiak Life Sciences, NGM Pharmaceuticals, Ocular Therepeutix, Opthea, Regeneron Pharmaceuticals, Inc., REGENXBIO, and Rezolute; served as a consultant/advisor for Adverum, Apellis, Genentech, and REGENXBIO.
